# Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.

> **NCT07311759** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Cairo University** · enrollment: 21 (estimated)

## Conditions studied

- Chronic Paronychia

## Interventions

- **DRUG:** Intralesional triamcinolone acetonide and fluconazole
- **DRUG:** Topical mometasone furoate and miconazole nitrate, Elica-M®

## Key facts

- **NCT ID:** NCT07311759
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-17
- **Primary completion:** 2025-12-04
- **Final completion:** 2026-05
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07311759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07311759, "Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07311759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*